AAV Downstream Process Development Intern - Cambridge, MA jobs in United States
cer-icon
Apply on Employer Site
company-logo

Alexion Pharmaceuticals, Inc. · 3 weeks ago

AAV Downstream Process Development Intern - Cambridge, MA

Alexion Pharmaceuticals, Inc. is looking for undergraduate senior and Master's level students for a 10-week internship role. The intern will independently execute chromatography and filtration unit operations, support experimental workflows, and analyze results from experiments to present findings to the team.

BiotechnologyHealth CareMedicalTherapeutics
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Independently execute chromatography and filtration unit operations
Work with matrix teams to support experimental workflows
Curate and analyze results from executed experiments, present findings to immediate team and broader group

Qualification

Wet lab skillsData analysisData visualizationFirst principles modelingTeam collaboration

Required

Undergraduate senior and Master's level students majoring in Chemical Engineering, Biomedical Engineering, or a related discipline. Candidates must have an expected graduation date after August 2026
Wet lab skills such as pipetting, sample handling and preparation (of biological samples) are required
Comfortability working in matrix team environments, presenting findings to mentors and group members in meetings is required
Ability to report onsite to Cambridge, MA 5 days per week. This role will not provide relocation assistance
US Work Authorization is required at time of application
This role will not be providing CPT support

Preferred

Experience with data analysis (using Excel, R etc.) and data visualization (Excel, Prism etc.) is preferred
Understanding of relevant/applicable trends in AI for data analysis and understanding of first principles modeling is preferred

Company

Alexion Pharmaceuticals, Inc.

company-logo
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.

Funding

Current Stage
Public Company
Total Funding
$5.8M
2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO

Leadership Team

leader-logo
Frederic Chereau
SVP, Strategy and Business Development
linkedin
leader-logo
Imran Shakur
Director, IRT and Technology Lead
linkedin
Company data provided by crunchbase